(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three biggest winners today are Artelo Biosciences, Senmiao Technology Limited, and Applied Therapeutics.

The three biggest losers today are FIRST REPUBLIC BANK, Akari Therapeutics Plc, and TrueBlue.

Winners today

1. Artelo Biosciences (ARTLW) – 17.79%

NASDAQ ended the session with Artelo Biosciences rising 17.79% to $0.07 on Tuesday, after five successive sessions in a row of losses. NASDAQ fell 1.98% to $11,799.16, following the last session’s downward trend on what was an all-around negative trend trading session today.

Yearly Top and Bottom Value

Artelo Biosciences’s stock is valued at $0.07 at 17:32 EST, higher than its 52-week high of $0.07.

More news about Artelo Biosciences.

2. Senmiao Technology Limited (AIHS) – 16.67%

Senmiao Technology Limited engages in the automobile transaction and related services business in the People's Republic of China. Its services include the facilitation of automobile transaction and financing, connecting ride-hailing drivers to financial institutions to buy, or get financing on the purchase of, cars to be used to provide ride-hailing services. The company is also involved in the sale of automobiles; and provision of auto finance services. Senmiao Technology has strategic cooperation with Gaode Map for utilization in ride sharing initiatives. Senmiao Technology Limited was incorporated in 2017 and is based in Chengdu, the People's Republic of China.

NASDAQ ended the session with Senmiao Technology Limited rising 16.67% to $1.01 on Tuesday while NASDAQ slid 1.98% to $11,799.16.

Earnings Per Share

As for profitability, Senmiao Technology Limited has a trailing twelve months EPS of $-1.2.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -50.8%.

Volume

Today’s last reported volume for Senmiao Technology Limited is 169944 which is 124.08% above its average volume of 75839.

More news about Senmiao Technology Limited.

3. Applied Therapeutics (APLT) – 16.28%

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase I/II for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials for treating diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy. Its preclinical stage products include AT-003 for the treatment diabetic retinopathy; AT-104, a PI3K inhibitor for treating orphan hematological oncology T Cell Acute Lymphoblastic Leukemia. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.

NASDAQ ended the session with Applied Therapeutics rising 16.28% to $1.10 on Tuesday, following the last session’s upward trend. NASDAQ slid 1.98% to $11,799.16, following the last session’s downward trend on what was an all-around bearish trend exchanging session today.

Earnings Per Share

As for profitability, Applied Therapeutics has a trailing twelve months EPS of $-2.18.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -247.77%.

Yearly Top and Bottom Value

Applied Therapeutics’s stock is valued at $1.10 at 17:32 EST, way under its 52-week high of $2.15 and way higher than its 52-week low of $0.50.

More news about Applied Therapeutics.

4. Xerox Corporation (XRX) – 14.39%

Xerox Holdings Corporation, a workplace technology company, designs, develops, and sells document management systems and solutions in the Americas, Europe, the Middle East, Africa, India, and internationally. It offers workplace solutions, including desktop monochrome, and color and multifunction printers; digital printing presses and light production devices, and solutions; and digital services that leverage workflow automation, personalization and communication software, content management solutions, and digitization services. The company also provides graphic communications and production solutions; and IT services, end user computing devices, network infrastructure, communications technology, and a range of managed IT solutions, such as technology product support, professional engineering, and commercial robotic process automation; and provides finance for the sale of Xerox, non-Xerox office, and IT services equipment. In addition, it provides FreeFlow a portfolio of software solutions for the automation and integration to the processing of print job comprises file preparation, final production, and electronic publishing. Further, the company sells paper products and wide-format systems, licensing, as well as standalone software such as CareAR, DocuShare, and XMPie. The company sells its products and services directly to its customers through its direct sales force, as well as through independent agents, dealers, value-added resellers, systems integrators, and e-commerce marketplaces. Xerox Holdings Corporation was founded in 1906 and is headquartered in Norwalk, Connecticut.

NYSE ended the session with Xerox Corporation rising 14.39% to $15.55 on Tuesday while NYSE slid 1.56% to $15,363.53.

Earnings Per Share

As for profitability, Xerox Corporation has a trailing twelve months EPS of $-2.15.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -7.81%.

Volatility

Xerox Corporation’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.30%, a negative 0.22%, and a positive 1.65%.

Xerox Corporation’s highest amplitude of average volatility was 2.30% (last week), 1.81% (last month), and 1.65% (last quarter).

Moving Average

Xerox Corporation’s worth is under its 50-day moving average of $15.73 and below its 200-day moving average of $15.75.

Yearly Top and Bottom Value

Xerox Corporation’s stock is valued at $15.55 at 17:32 EST, way below its 52-week high of $20.29 and way above its 52-week low of $11.80.

Sales Growth

Xerox Corporation’s sales growth is 4.2% for the current quarter and 1.2% for the next.

More news about Xerox Corporation.

5. Adial Pharmaceuticals (ADIL) – 13.85%

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in phase 3 clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Charlottesville, Virginia.

NASDAQ ended the session with Adial Pharmaceuticals rising 13.85% to $0.37 on Tuesday while NASDAQ slid 1.98% to $11,799.16.

Earnings Per Share

As for profitability, Adial Pharmaceuticals has a trailing twelve months EPS of $-0.55.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -375.32%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Adial Pharmaceuticals’s EBITDA is -0.07.

More news about Adial Pharmaceuticals.

6. Brooge Energy Limited (BROGW) – 12.5%

NASDAQ ended the session with Brooge Energy Limited jumping 12.5% to $0.09 on Tuesday while NASDAQ slid 1.98% to $11,799.16.

Yearly Top and Bottom Value

Brooge Energy Limited ‘s stock is valued at $0.09 at 17:32 EST, under its 52-week low of $0.09.

More news about Brooge Energy Limited .

7. Aqua Metals (AQMS) – 10.58%

Aqua Metals, Inc. engages in the recycling of lead primarily in the United States. It produces and sells hard lead, lead compounds, and plastics. The company was incorporated in 2014 and is headquartered in McCarran, Nevada.

NASDAQ ended the session with Aqua Metals jumping 10.58% to $1.15 on Tuesday, following the last session’s upward trend. NASDAQ slid 1.98% to $11,799.16, following the last session’s downward trend on what was an all-around down trend trading session today.

Earnings Per Share

As for profitability, Aqua Metals has a trailing twelve months EPS of $-0.2.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -63.7%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 100%, now sitting on 4k for the twelve trailing months.

Volume

Today’s last reported volume for Aqua Metals is 379068 which is 30.61% above its average volume of 290222.

Sales Growth

Aqua Metals’s sales growth for the next quarter is 900%.

More news about Aqua Metals.

8. AGBA Acquisition Limited (AGBA) – 8.82%

AGBA Acquisition Limited does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2018 and is based in Tsim Sha Tsui, Hong Kong.

NASDAQ ended the session with AGBA Acquisition Limited jumping 8.82% to $2.22 on Tuesday while NASDAQ dropped 1.98% to $11,799.16.

Earnings Per Share

As for profitability, AGBA Acquisition Limited has a trailing twelve months EPS of $-0.85.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -136.37%.

Yearly Top and Bottom Value

AGBA Acquisition Limited’s stock is valued at $2.22 at 17:32 EST, way under its 52-week high of $11.81 and way higher than its 52-week low of $1.31.

Moving Average

AGBA Acquisition Limited’s value is way higher than its 50-day moving average of $1.98 and way under its 200-day moving average of $6.45.

Volume

Today’s last reported volume for AGBA Acquisition Limited is 203020 which is 269% above its average volume of 55019.

Revenue Growth

Year-on-year quarterly revenue growth grew by 373.1%, now sitting on 31.08M for the twelve trailing months.

More news about AGBA Acquisition Limited.

9. Brilliant Acquisition Corporation (BRLIR) – 8.46%

NASDAQ ended the session with Brilliant Acquisition Corporation jumping 8.46% to $0.20 on Tuesday, after five successive sessions in a row of losses. NASDAQ dropped 1.98% to $11,799.16, following the last session’s downward trend on what was an all-around bearish trend exchanging session today.

More news about Brilliant Acquisition Corporation.

10. Benitec Biopharma (BNTC) – 6.53%

Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy and chronic hepatitis B virus infection. The company was founded in 1995 and is headquartered in Hayward, California.

NASDAQ ended the session with Benitec Biopharma rising 6.53% to $0.22 on Tuesday while NASDAQ slid 1.98% to $11,799.16.

Earnings Per Share

As for profitability, Benitec Biopharma has a trailing twelve months EPS of $-1.47.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -190.07%.

Moving Average

Benitec Biopharma’s value is below its 50-day moving average of $0.24 and way under its 200-day moving average of $0.37.

More news about Benitec Biopharma.

Losers Today

1. FIRST REPUBLIC BANK (FRC) – -48.53%

First Republic Bank, together with its subsidiaries, provides private banking, private business banking, and private wealth management services to clients in metropolitan areas in the United States. It operates in two segments, Commercial Banking and Wealth Management. The company accepts deposit products, such as noninterest-bearing checking, interest-bearing checking, money market checking accounts, money market savings accounts, and passbook accounts, as well as certificates of deposit. It also offers a range of lending products that comprise residential mortgage loans, home equity lines of credit, multifamily loans, commercial real estate and construction loans, personal and business loans, single family construction loans, and other loans and lines of credit to businesses and individuals. The company's loans are secured by single family residences, multifamily buildings, and commercial real estate properties. In addition, it provides wealth management services, which include various investment strategies and products, online investment management, trust and custody, full service and online brokerage, financial and estate planning, and access to alternative investments, as well as investing, insurance, and foreign exchange services. Further, the company offers online and mobile banking services; refinancing services; and ATM and debit cards. First Republic Bank was founded in 1985 and is headquartered in San Francisco, California.

NYSE ended the session with FIRST REPUBLIC BANK sliding 48.53% to $8.23 on Tuesday while NYSE slid 1.56% to $15,363.53.

Earnings Per Share

As for profitability, FIRST REPUBLIC BANK has a trailing twelve months EPS of $9.26.

PE Ratio

FIRST REPUBLIC BANK has a trailing twelve months price to earnings ratio of 0.89. Meaning, the purchaser of the share is investing $0.89 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.99%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 4.8%, now sitting on 5.76B for the twelve trailing months.

Volume

Today’s last reported volume for FIRST REPUBLIC BANK is 176695000 which is 374.02% above its average volume of 37275600.

Moving Average

FIRST REPUBLIC BANK’s worth is way under its 50-day moving average of $74.11 and way under its 200-day moving average of $121.44.

More news about FIRST REPUBLIC BANK.

2. Akari Therapeutics Plc (AKTX) – -21.43%

Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of treatments for autoinflammatory diseases that involve complement and leukotriene pathways. Its lead product candidate is nomacopan, a second-generation complement inhibitor that is in Phase II clinical trial for the treatment of autoimmune and inflammatory diseases, including paroxysmal nocturnal hemoglobinuria, guillain barré syndrome, hematopoietic stem cell transplant-associated thrombotic microangiopathy, and bullous pemphigoid. Akari Therapeutics, Plc is based in London, the United Kingdom.

NASDAQ ended the session with Akari Therapeutics Plc dropping 21.43% to $0.18 on Tuesday, following the last session’s downward trend. NASDAQ slid 1.98% to $11,799.16, following the last session’s downward trend on what was an all-around down trend exchanging session today.

Earnings Per Share

As for profitability, Akari Therapeutics Plc has a trailing twelve months EPS of $-0.35.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -365.06%.

More news about Akari Therapeutics Plc.

3. TrueBlue (TBI) – -15.74%

TrueBlue, Inc., together with its subsidiaries, provides specialized workforce solutions in the United States, Canada, the United Kingdom, Australia, and Puerto Rico. It operates through three segments: PeopleReady, PeopleManagement, and PeopleScout. The company's PeopleReady segment provides general, industrial, and skilled trade staffing services for construction, transportation, manufacturing, retail, hospitality, and renewable energy industries. Its PeopleManagement segment offers contingent, on-site industrial staffing, and commercial driver services, which includes on-site management and recruitment for the contingent industrial workforce of manufacturing, warehouse, and distribution facilities; and recruitment and management of contingent and dedicated commercial drivers to the transportation and distribution industries under the Staff Management, SIMOS Insourcing Solutions, and Centerline Drivers brands. The company's PeopleScout segment provides recruitment process outsourcing, talent advisory services, and managed service provider solutions including sourcing, screening, hiring, and onboarding services; operates Affinix, a technology platform which uses artificial intelligence and machine learning for real-time insights; and contingent labor programs including vendor selection, performance management, compliance monitoring, and risk management. TrueBlue, Inc. was formerly known as Labor Ready, Inc. and changed its name to TrueBlue, Inc. in December 2007. The company is headquartered in Tacoma, Washington.

NYSE ended the session with TrueBlue falling 15.74% to $14.56 on Tuesday while NYSE dropped 1.56% to $15,363.53.

Earnings Per Share

As for profitability, TrueBlue has a trailing twelve months EPS of $1.83.

PE Ratio

TrueBlue has a trailing twelve months price to earnings ratio of 7.96. Meaning, the purchaser of the share is investing $7.96 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.59%.

Volatility

TrueBlue’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.43%, a positive 0.25%, and a positive 1.48%.

TrueBlue’s highest amplitude of average volatility was 1.43% (last week), 1.08% (last month), and 1.48% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth declined by 10.3%, now sitting on 2.25B for the twelve trailing months.

More news about TrueBlue.

4. Aethlon Medical (AEMD) – -13.44%

Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. It is also developing TauSome, an exosomal biomarker candidate to diagnose chronic traumatic encephalopathy in living individuals. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.

NASDAQ ended the session with Aethlon Medical falling 13.44% to $0.53 on Tuesday while NASDAQ slid 1.98% to $11,799.16.

Earnings Per Share

As for profitability, Aethlon Medical has a trailing twelve months EPS of $-1.06.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -70.56%.

Yearly Top and Bottom Value

Aethlon Medical’s stock is valued at $0.53 at 17:32 EST, way below its 52-week high of $2.46 and way above its 52-week low of $0.23.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 50% and 31.6%, respectively.

Moving Average

Aethlon Medical’s worth is way higher than its 50-day moving average of $0.44 and way under its 200-day moving average of $0.65.

More news about Aethlon Medical.

5. Redfin (RDFN) – -12.1%

Redfin Corporation operates as a residential real estate brokerage company in the United States and Canada. The company operates an online real estate marketplace and provides real estate services, including assisting individuals in the purchase or sell of home. It also provides title and settlement services; and originates and sells mortgages. The company was formerly known as Appliance Computing Inc. and changed its name to Redfin Corporation in May 2006. Redfin Corporation was incorporated in 2002 and is headquartered in Seattle, Washington.

NASDAQ ended the session with Redfin falling 12.1% to $7.44 on Tuesday while NASDAQ fell 1.98% to $11,799.16.

Earnings Per Share

As for profitability, Redfin has a trailing twelve months EPS of $-2.99.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -141.6%.

Volume

Today’s last reported volume for Redfin is 3140640 which is 18.99% below its average volume of 3877040.

Growth Estimates Quarters

The company’s growth estimates for the current quarter is a negative 15.1% and positive 50.7% for the next.

Volatility

Redfin’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.96%, a positive 0.75%, and a positive 5.40%.

Redfin’s highest amplitude of average volatility was 2.30% (last week), 3.71% (last month), and 5.40% (last quarter).

More news about Redfin.

6. MSCI (MSCI) – -11.28%

MSCI Inc., together with its subsidiaries, provides investment decision support tools for the clients to manage their investment processes worldwide. It operates through four segments: Index, Analytics, ESG and Climate, and All Other – Private Assets. The Index segment provides indexes for use in various areas of the investment process, including indexed product creation, such as ETFs, mutual funds, annuities, futures, options, structured products, over-the-counter derivatives; performance benchmarking; portfolio construction and rebalancing; and asset allocation, as well as licenses GICS and GICS Direct. The Analytics segment offers risk management, performance attribution and portfolio management content, application, and service that provides an integrated view of risk and return, and an analysis of market, credit, liquidity, and counterparty risk across asset classes; managed services, including consolidation of client portfolio data from various sources, review and reconciliation of input data and results, and customized reporting; and HedgePlatform to measure, evaluate, and monitor the risk of hedge fund investments. The ESG and Climate segment provides products and services that help institutional investors understand how ESG factors impact the long-term risk and return of their portfolio and individual security-level investments; and data, ratings, research, and tools to help investors navigate increasing regulation. The All Other – Private Assets segment includes real estate market and transaction data, benchmarks, return-analytics, climate assessments and market insights for funds, investors, and managers; business intelligence to real estate owners, managers, developers, and brokers; and offers investment decision support tools for private capital. It serves asset owners and managers, financial intermediaries, wealth managers, real estate professionals, and corporates. MSCI Inc. was incorporated in 1998 and is headquartered in New York, New York.

NYSE ended the session with MSCI dropping 11.28% to $483.18 on Tuesday, after two sequential sessions in a row of losses. NYSE dropped 1.56% to $15,363.53, following the last session’s upward trend on what was an all-around negative trend trading session today.

MSCI (msci) beats Q1 earnings estimatesWhile MSCI has outperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?

Earnings Per Share

As for profitability, MSCI has a trailing twelve months EPS of $10.73.

PE Ratio

MSCI has a trailing twelve months price to earnings ratio of 45.03. Meaning, the purchaser of the share is investing $45.03 for every dollar of annual earnings.

Volatility

MSCI’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.01%, a negative 0.01%, and a positive 1.35%.

MSCI’s highest amplitude of average volatility was 0.25% (last week), 0.94% (last month), and 1.35% (last quarter).

Moving Average

MSCI’s value is way below its 50-day moving average of $540.43 and below its 200-day moving average of $488.56.

Yearly Top and Bottom Value

MSCI’s stock is valued at $483.18 at 17:32 EST, way below its 52-week high of $572.50 and way above its 52-week low of $376.41.

Previous days news about MSCI

• First MSCI index based crypto ETP launched by ETC group starts trading on xetra. According to GlobeNewsWire on Monday, 24 April, "The new exchange-traded product tracks the performance of the MSCI Global Digital Assets Top 20 Capped Index and is listed under its primary ticker DA20. ", "Like all ETC Group products, the ETC Group MSCI Digital Assets Select 20 is fully backed by the underlying digital assets and issuer default risk is minimised via an independent trustee. "

More news about MSCI.

7. Aptevo Therapeutics (APVO) – -10.27%

Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1/1b clinical trial for acute myelogenous leukemia and myelodysplastic syndrome. The company's preclinical candidates also include ALG.APV-527, an investigational bispecific ADAPTIR candidate that features a mechanism of action to target 4-1BB (CD137) and 5T4, a tumor antigen expressed in various types of cancers; and APVO603, a dual agonist bispecific antibody to target 4-1BB and OX40. It is also developing APVO442, a bispecific candidate based on the ADAPTIR-FLEX platform technology to enhance biodistribution of drugs to PSMA positive tumors for treatment of prostate cancer; and other pre-clinical development stage therapeutics focused on hematologic and solid tumors. It has a collaboration and option agreement with Alligator Bioscience AB to develop ALG.APV-527. Aptevo Therapeutics Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.

NASDAQ ended the session with Aptevo Therapeutics dropping 10.27% to $1.66 on Tuesday while NASDAQ fell 1.98% to $11,799.16.

Earnings Per Share

As for profitability, Aptevo Therapeutics has a trailing twelve months EPS of $1.39.

PE Ratio

Aptevo Therapeutics has a trailing twelve months price to earnings ratio of 1.19. Meaning, the purchaser of the share is investing $1.19 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 73.1%.

More news about Aptevo Therapeutics.

8. UPS (UPS) – -9.8%

United Parcel Service, Inc., a package delivery company, provides transportation and delivery, distribution, contract logistics, ocean freight, airfreight, customs brokerage, and insurance services. It operates through two segments, U.S. Domestic Package and International Package. The U.S. Domestic Package segment offers time-definite delivery of letters, documents, small packages, and palletized freight through air and ground services in the United States. The International Package segment provides guaranteed day and time-definite international shipping services comprising guaranteed time-definite express options in Europe, Asia, the Indian sub-continent, the Middle East, Africa, Canada, and Latin America. The company also provides international air and ocean freight forwarding, post-sales, and mail and consulting services. In addition, it offers truckload brokerage services; supply chain solutions to the healthcare and life sciences industries; financial and information services; and fulfillment and transportation management services. United Parcel Service, Inc. was founded in 1907 and is headquartered in Atlanta, Georgia.

NYSE ended the session with UPS dropping 9.8% to $176.65 on Tuesday, after four sequential sessions in a row of gains. NYSE dropped 1.56% to $15,363.53, following the last session’s upward trend on what was an all-around negative trend exchanging session today.

: UPS stock falls after profit matches expectations but revenue comes up shy and outlook was trimmedShares of United Parcel Service Inc. UPS slumped 3.4% in premarket trading Tuesday, after the package delivery giant reported first-quarter profit that matched expectations but revenue that fell a bit shy and trimmed its full-year outlook.

UPS shares slump as revenue forecast reducedShares of United Parcel Service Inc. UPS slumped 3.4% in premarket trading Tuesday, after the package delivery giant reported first-quarter profit that matched expectations but revenue that fell a bit shy and trimmed its full-year outlook.

Earnings Per Share

As for profitability, UPS has a trailing twelve months EPS of $13.2.

PE Ratio

UPS has a trailing twelve months price to earnings ratio of 13.38. Meaning, the purchaser of the share is investing $13.38 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 67.79%.

More news about UPS.

9. Danaher Corporation (DHR) – -9.07%

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, municipal, industrial, and natural resource applications. It also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. The company was founded in 1969 and is headquartered in Washington, the District of Columbia.

NYSE ended the session with Danaher Corporation sliding 9.07% to $231.27 on Tuesday, after four sequential sessions in a row of gains. NYSE fell 1.56% to $15,363.53, following the last session’s upward trend on what was an all-around negative trend exchanging session today.

Earnings Per Share

As for profitability, Danaher Corporation has a trailing twelve months EPS of $9.66.

PE Ratio

Danaher Corporation has a trailing twelve months price to earnings ratio of 23.94. Meaning, the purchaser of the share is investing $23.94 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.13%.

Yearly Top and Bottom Value

Danaher Corporation’s stock is valued at $231.27 at 17:32 EST, below its 52-week low of $233.71.

More news about Danaher Corporation.

10. Northern Trust (NTRS) – -9.06%

Northern Trust Corporation, a financial holding company, provides wealth management, asset servicing, asset management, and banking solutions for corporations, institutions, families, and individuals worldwide. It operates in two segments, Asset Servicing and Wealth Management. The Asset Servicing segment offers asset servicing and related services, including custody, fund administration, investment operations outsourcing, investment management, investment risk and analytical services, employee benefit services, securities lending, foreign exchange, treasury management, brokerage services, transition management services, banking, and cash management services. This segment serves corporate and public retirement funds, foundations, endowments, fund managers, insurance companies, sovereign wealth funds, and other institutional investors. The Wealth Management segment offers trust, investment management, custody, and philanthropic; financial consulting; guardianship and estate administration; family business consulting; family financial education; brokerage services; and private and business banking services. This segment serves high-net-worth individuals and families, business owners, executives, professionals, retirees, and established privately held businesses. The company also provides asset management services, such as active and passive equity; active and passive fixed income; cash management; alternative asset classes comprising private equity and hedge funds of funds; and multi-manager advisory services and products through separately managed accounts, bank common and collective funds, registered investment companies, exchange traded funds, non-U.S. collective investment funds, and unregistered private investment funds. In addition, it offers overlay and other risk management services. Northern Trust Corporation was founded in 1889 and is headquartered in Chicago, Illinois.

NASDAQ ended the session with Northern Trust sliding 9.06% to $78.33 on Tuesday, following the last session’s upward trend. NASDAQ slid 1.98% to $11,799.16, following the last session’s downward trend on what was an all-around bearish trend exchanging session today.

Northern trust corporation (ntrs) Q1 earnings meet estimatesWhile Northern Trust Corporation has underperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?, Ahead of this earnings release, the estimate revisions trend for Northern Trust Corporation: mixed.

Earnings Per Share

As for profitability, Northern Trust has a trailing twelve months EPS of $6.08.

PE Ratio

Northern Trust has a trailing twelve months price to earnings ratio of 12.88. Meaning, the purchaser of the share is investing $12.88 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.48%.

Moving Average

Northern Trust’s value is way under its 50-day moving average of $90.78 and way below its 200-day moving average of $92.14.

Sales Growth

Northern Trust’s sales growth is 2.9% for the current quarter and 1.8% for the next.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Mar 8, 2023, the estimated forward annual dividend rate is 3 and the estimated forward annual dividend yield is 3.41%.

Volatility

Northern Trust’s last week, last month’s, and last quarter’s current intraday variation average was 0.04%, 0.16%, and 1.59%.

Northern Trust’s highest amplitude of average volatility was 1.03% (last week), 1.14% (last month), and 1.59% (last quarter).

More news about Northern Trust.

Stay up to date with our winners and losers daily report